Drug Type Small molecule drug |
Synonyms SL 850274, SL-85.0274, SL-850274 |
Target |
Action agonists |
Mechanism GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H20ClN3O |
InChIKeyLIFDPEORUVTOCP-UHFFFAOYSA-N |
CAS Registry103844-86-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Saripidem | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anxiety Disorders | Phase 2 | France | - | |
Anxiety Disorders | Phase 2 | - | - |